This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Long-term, 25-year Survival Following Surgery and Immune Cell Therapy Combined with Chemotherapy for HER2-Positive Metastatic Breast Cancer: A Case Report. Issue 2 (2021)
Record Type:
Journal Article
Title:
Long-term, 25-year Survival Following Surgery and Immune Cell Therapy Combined with Chemotherapy for HER2-Positive Metastatic Breast Cancer: A Case Report. Issue 2 (2021)
Main Title:
Long-term, 25-year Survival Following Surgery and Immune Cell Therapy Combined with Chemotherapy for HER2-Positive Metastatic Breast Cancer: A Case Report